Trovagene Q4 Revenues Slide 71 Percent | GenomeWeb

NEW YORK (GenomeWeb News) – Trovagene reported after the close of the market on Monday a 71 percent drop in revenues for its fourth quarter.

The San Diego-based molecular diagnostics firm posted $47,000 in revenues for the three months ended Dec. 31, 2013, down from $163,000 a year ago.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: variant linked to obesity risk in Samoans, health of cloned animals, and more.

Researchers explore using genome editing to treat inherited eye diseases, New Scientist reports.

Olympic athletes this summer will also undergo gene doping testing, according to Wired.

A study finds that the lower funding rate seen among women of color is more due to race than gender, according to BuzzFeed News.